| Bioactivity | Enbezotinib (enantiomer) (Compound 44) is the enantiomer form of Enbezotinib (HY-145565). Enbezotinib is an inhibitor of RET[1]. |
| Name | Enbezotinib (enantiomer) |
| CAS | 2359650-19-2 |
| Formula | C21H21FN6O3 |
| Molar Mass | 424.43 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Evan W. ROGERS, et, al. Macrocyclic compounds for treating disease. Patent. WO2019126121 A1. |
Enbezotinib (enantiomer)
CAS: 2359650-19-2 F: C21H21FN6O3 W: 424.43
Enbezotinib (enantiomer) (Compound 44) is the enantiomer form of Enbezotinib (HY-145565). Enbezotinib is an inhibitor of
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.